Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Forge Resources Intercepts 105 G/T Au in the Payoff Zone at Alotta Project, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Ownership  |  Insiders

Bullboard - Stock Discussion Forum EyePoint Pharmaceuticals Inc EYPT

Healthcare Biotechnology
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing innovative therapeutics to help improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated... see more

Bullboard (NDAQ:EYPT)

View:
User Avatar Image
(0)
•••
  • PumperGuyX
Post by PumperGuyon Jan 22, 2024 5:40pm

I "SEE" nothing but $$$$$$$ Coming our way!

Here's to LOOKING up!!
94
User Avatar Image
(4)
•••
  • AviseAnalyticsX
Post by AviseAnalyticson Jan 05, 2024 8:10am

EYEPOINT PHARMACEUTICALS: A BOON FOR EYE DISEASE PATIENTS

$EYPT Excited to share an article about EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) - the Company develops and commercializes therapeutics to improve the lives of patients with severe eye disorders. ...more  
115
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >